Centerpoint Advisory Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Centerpoint Advisory Group's AMGN Position: Q3 2026 in Review
Centerpoint Advisory Group opened a new position in Amgen (AMGN) in Q3 2026: 532 shares worth $224K. The stake represents 0.14% of the portfolio and ranks #104 among its holdings. This is a return to the name: Centerpoint Advisory Group previously reported a position in AMGN as recently as Q1 2025.
Centerpoint Advisory Group first reported a position in AMGN in Q4 2024 and has held it in 3 quarters since. The position peaked at $359K in Q1 2025. 3,270 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Centerpoint Advisory Group held 532 shares of Amgen worth $224K as of Q3 2026.
- Amgen was a new Centerpoint Advisory Group position in Q3 2026.
- Amgen made up 0.14% of Centerpoint Advisory Group's portfolio in Q3 2026, its #104 holding.
- Centerpoint Advisory Group first reported a position in Amgen in Q4 2024 and has held it in 3 quarters since.
- Centerpoint Advisory Group's Amgen position peaked at $359K in Q1 2025.
- 3,270 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Centerpoint Advisory Group's 13F filing for Q3 2026, filed 23 Oct 2026.